KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Shares Issued (2016 - 2025)

Historic Shares Issued for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $4.1 million.

  • Travere Therapeutics' Shares Issued changed N/A to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year increase of 1078194.34%. This contributed to the annual value of $134.7 million for FY2024, which is 2952.96% down from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Shares Issued is $4.1 million.
  • In the past 5 years, Travere Therapeutics' Shares Issued registered a high of $182.6 million during Q4 2021, and its lowest value of $122000.0 during Q1 2022.
  • Over the past 5 years, Travere Therapeutics' median Shares Issued value was $2.8 million (recorded in 2022), while the average stood at $27.8 million.
  • As far as peak fluctuations go, Travere Therapeutics' Shares Issued crashed by 9970.65% in 2021, and later soared by 2008852.46% in 2023.
  • Over the past 5 years, Travere Therapeutics' Shares Issued (Quarter) stood at $182.6 million in 2021, then crashed by 98.45% to $2.8 million in 2022, then soared by 771.86% to $24.6 million in 2023, then soared by 441.74% to $133.4 million in 2024, then tumbled by 96.93% to $4.1 million in 2025.
  • Its Shares Issued stands at $4.1 million for Q3 2025, versus $463000.0 for Q2 2025 and $4.2 million for Q1 2025.